{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:53:42Z","timestamp":1772805222949,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s72701","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T19:57:57Z","timestamp":1435694277000},"page":"887","source":"Crossref","is-referenced-by-count":6,"title":["Patient considerations in the management of toe onychomycosis – role of efinaconazole"],"prefix":"10.2147","author":[{"given":"Antonella","family":"Tosti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"LaSenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=25727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:40:52Z","timestamp":1477852852000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/patient-considerations-in-the-management-of-toe-onychomycosis-ndash-ro-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s72701","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}